Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Tuesday, March 2, 2021
EMERYVILLE, Calif., Feb. 17, 2021 /PRNewswire/ -- Amyris, Inc.. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Tuesday, March 2, 2021, prior to the opening of the financial markets. The company will hold a conference call and live audio webcast at 6:00 am Pacific Time (9:00 a.m. Eastern Time). On the call, John Melo, President and Chief Executive Officer, Han Kieftenbeld, Chief Financial Officer, and Eduardo Alvarez, Chief Operating Officer, will provide an update on Amyris’s financial results and the company’s business. Live audio webcast/conference call: Please connect to the website or dial in to the conference call 15 minutes prior to the start of the call to avoid connection delays. If a participant will be listen-only, they are encouraged to listen via the webcast on Amyris’s investor page. A replay of the webcast will be available on the Investor Relations section of the company’s website. About Amyris Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and Purecane are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
View original content to download multimedia:http://www.prnewswire.com/news-releases/amyris-to-host-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-march-2-301229754.html SOURCE Amyris, Inc. | ||
Company Codes: NASDAQ-NMS:AMRS |